Healthy volunteers help test drug safety for cystic fibrosis treatment
NCT ID NCT07349394
First seen Jan 19, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study looked at how a cystic fibrosis drug combination (vanzacaftor/tezacaftor/deutivacaftor) affects the way the body processes a common cholesterol drug called rosuvastatin. 18 healthy adults took both medications, and researchers measured drug levels and checked for side effects. The goal was to understand potential drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences - Kansas City
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.